Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autoimmunity and type I diabetes.

J F Bach1

  • 1INSERM U 25, Hôpital Necker,Paris,France.

Trends in Endocrinology and Metabolism: TEM
|March 1, 1997
PubMed
Summary
This summary is machine-generated.

Insulin-dependent diabetes mellitus (IDDM) is an autoimmune disease where T-cells destroy beta-cells. Immune dysregulation involving T-helper 2 (TH2) cells amplifies this T-helper 1 (TH1) response, influenced by genetic factors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[T CD57+ lymphocytes in kidney transplanted patients. Phenotypic and functional study].

Presse medicale (Paris, France : 1983)·1992
Same author

[Routine application of HLA class II oligotyping. Value of automatization].

Presse medicale (Paris, France : 1983)·1992
Same author

Evidence that antihuman tumor necrosis factor monoclonal antibody prevents OKT3-induced acute syndrome.

Transplantation·1992
Same author

Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus.

The Journal of clinical investigation·1992
Same author

A1B8DR3-associated CD8-positive T-cell expansion in HIV infection.

Lancet (London, England)·1992
Same author

[A new approach of prevention: predictive medicine].

Pathologie-biologie·1992
Same journal

Beyond fat storage: neuronal lipid droplets regulate whole-body metabolism.

Trends in endocrinology and metabolism: TEM·2026
Same journal

HDL resuscitates cells from ferroptosis.

Trends in endocrinology and metabolism: TEM·2026
Same journal

2-Methylbutyrylcarnitine (2MBC).

Trends in endocrinology and metabolism: TEM·2026
Same journal

Decoding growth hormone actions on human growth plate stem cells.

Trends in endocrinology and metabolism: TEM·2026
Same journal

Androgen loss backfires: Brain gate for tumor immunity.

Trends in endocrinology and metabolism: TEM·2026
Same journal

Glucocorticoid resistance-induced inflammation drives cardiovascular-kidney-metabolic (CKM) syndrome pathophysiology.

Trends in endocrinology and metabolism: TEM·2026
See all related articles

Area of Science:

  • Endocrinology
  • Immunology
  • Genetics

Background:

  • Insulin-dependent diabetes mellitus (IDDM) is a T-cell-mediated autoimmune disease.
  • Beta-cell destruction in IDDM is driven by cytokine-mediated inflammation.
  • Candidate autoantigens are identified for T-cell responses and antibody-based prediction.

Purpose of the Study:

  • To explore the role of autoantigens in triggering IDDM.
  • To understand the immune dysregulation perpetuating the autoimmune response.
  • To investigate the genetic control of effector and regulatory mechanisms in IDDM.

Main Methods:

  • Analysis of T-cell mediated autoimmune responses.
  • Delineation of candidate autoantigens.
  • Investigation of immune dysregulation involving T-helper cells.

Related Experiment Videos

  • Examination of major histocompatibility complex (MHC) and non-MHC gene influence.

    • Main Results:

    • Several candidate autoantigens have been identified for both pathogenic T-cell and non-pathogenic antibody responses.
    • Antigen spreading complicates the identification of initial triggering autoantigens.
    • A TH1 autoimmune response is amplified by immune dysregulation involving TH2 cells.

    Conclusions:

    • The precise autoantigens initiating IDDM remain unclear due to antigen spreading.
    • Immune dysregulation, particularly involving TH2 cells, amplifies the pathogenic TH1 response.
    • Both effector and regulatory immune mechanisms in IDDM are genetically controlled by MHC and non-MHC genes.